The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line

Neoplasma

Volumn 52, Issue 6, 2005, Pages 489-493

  Grzanka, A ^a   Zuryn A ^a   Styczynski J ^a   Grzanka, A A ^a   Wisniewska, H ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Apoptosis; Cell cycle; Cyclin A; Doxorubicin; K 562 cells

Indexed keywords

BIOTIN; CELL PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; DOXORUBICIN; PEROXIDASE; STREPTAVIDIN;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; CYTOPHOTOMETRY; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 29144520512     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ANDERSON JA, LEWELLYN AL, MALLER JL. Ionizing radiation induces apoptosis and elevates cyclin A-Cdk2 activity before but not after the midblastula transition in Xenopus. Mol Biol Cell 1997; 8: 1195-1206.
2. ALLAN K, JORDAN RC, ANG LC, TAYLOR M, YOUNG B. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas. Arch Lab Med 2000; 124: 216-220.
3. BORGNE A, GOLSTEYN RM. The role of cyclin-dependent kinases in apoptosis. Prog Cell Cycle Res 2003; 5: 453-459.
4. BRECHOT C. Oncogenic activation of cyclin A. Curr Opin Genet Dev 1993; 3: 11-18.
5. CHEN HC, HSIEH WT, CHANG WC, CHUNG JG. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 2004; 42: 1251-1257.
6. CONSTANTINOU A, GRDINA D, KIGUCHIK, HUBERMAN E. The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells. Exp Cell Res 1992; 203: 100-106.
7. CONSTANTINOU A, KIGUCHI K, HUBERMAN E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 1990; 50: 2618-2624.
8. EVAN GI, VOUSDEN KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342-348.
9. GONG J, BHATIA U, TRAGANOS F, DARZYNKJEWICZ Z. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry. Leukemia 1995; 9: 893-899.
10. GRZANKA A, STYCZYNSKI J. Expression of cyclin A in human leukemia cell lines HL-60 and K-562 at the level of light and electron microscope by using immunocytochemical methods. Neoplasma 2001; 48: 112-115.
11. HANDA K, YAMAKAWA M, TEKEDA H, KIMURA S, TAKAHASHI T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 1999; 84: 225-233.
12. HIROMURA K, PIPPIN JW, BLONSKI MJ, ROBERTS JM, SHANKLAND SJ. The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene 2002; 7: 1750-1758.
13. HOANG AT, COHEN KJ, BARRETT JF, BERGSTROM DA, DANG CV. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 1994; 91: 6875-6879.
14. HOLM C, GOTO T, WANG JC, BOTSTEIN D. DNA topoisomerase II is required of the time of mitosis in yeast. Cell 1985; 41: 553-563.
15. HUUHTANEN RL, BLOMQVIST CP, BOHLING TO, WIKLUNG TA, TUKIAINEN EJ et al. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res 1999; 59: 2885-2890.
16. JEONG MH, JIN YH, KANG EY, JO WS, PARK HT et al. The modulation of radiation-induced cell death by genistein in K-562 cells: activation of thymidyne kinase 1. Cell Res 2004; 14: 295-302.
17. KRAMER A, HOCHHAUS A, SAUSSELE S, REICHERT A, WILLER A et al. Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation. Leukemia 1998; 12: 893-898.
18. LIU LF. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989; 58: 351-375.
19. MEIKRANTZ W, GISSELBRECHT S, TAM SW, SCHLEGEL R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 1994; 91: 3754-3758.
20. NAKAMAKI T, HAMANO Y, HISATAKE J, YOKOYAMA A, KAWAKAMI K et al. Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival. Br J Haematol 2003; 123: 72-80.
21. NELSON WG, LIU LF, COFFEY DS. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cell. Nature 1986; 322: 187-189.
22. PATERLINI P, FLEJOU JF, DE MITRI MS, PISI E, FRANCO D et al. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J Hepatol 1995; 23: 47-52.
23. PATERLINIP, SUBERVILLE AM, ZINDY F, MELLE J, SONNIER M et al. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 1993; 53: 235-238.
24. PINES J. Aressting developments in cell-cycle control. Trends Biochem Sci 1994; 19: 143-145.
25. SU TT, CAMPBELL SD, O'FARRELL PH. Drosophila grapes/CHK1 mutants are defective in cyclin proteolysis and coordination of mitotic events. Curr Biol 1999; 9: 911-922.
26. UEMURA T, YANAGIDA M. Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis. EMBO J 1986; 5: 1003-1010.
27. VOLM M, KOOMAGIR, MATTERN J, STAMMLER G. Cyclin A is associated with an unfavorable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 1997; 75: 1774-1778.
28. VOLM M, RITTGEN w, DRINGS P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 1998; 77: 663-669.
29. WEINTRAUB H, CHENG PF, CONRAD K. Expression of transfected DNA depends on DNA topology. Cell 1986; 46: 115-122.
30. WOESSNER RD, CHUNG TD, HOFMANN GA, MATTERN MR, MIRABELLI CK et al. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II. Cancer Res 1990; 50: 2901-2908.
31. YANG JH, CHOU CC, CHENG YW, SHEEN LY, CHOU MC et al. Effects of glycolic acid on the induction of apoptosis via caspase-3 activation in human leukemia cell line (HL-60). Food Chem Toxicol 2004; 42: 1777-1784.
32. ZHAIYL, NIKAIDO T, SHIOZAWA T, ORII A, FUJII S. Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. Int J Cancer 1999; 84: 244-250.